Research & Literature

Staging systems and disease severity assessment in interstitial lung diseases.

Tomassetti S, Ryu JH, Poletti V

Current opinion in pulmonary medicine 2015; (21(5)):463-9 doi:10.1097/MCP.0000000000000198.

In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.

Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB

American journal of respiratory and critical care medicine 2016; (193(10)):1161-7 doi:10.1164/rccm.201508-1632OC.

Consensus document for the diagnosis and treatment of idiopathic pulmonary fibrosis: Joint Consensus of Sociedade Portuguesa de Pneumologia, Sociedade Portuguesa de Radiologia e Medicina Nuclear e Sociedade Portuguesa de Anatomia Patológica.

Robalo Cordeiro C, Campos P, Carvalho L, et al.

Revista portuguesa de pneumologia 2016; (22(2)):112-22.

Management of interstitial lung disease associated with connective tissue disease.

Mathai SC, Danoff SK

BMJ (Clinical research ed.) 2016; (352()):h6819 doi:10.1136/bmj.h6819.

High-resolution CT predictors of hypersensitivity pneumonitis.

Rival G, Manzoni P, Lacasse Y, et al.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2016; (33(2)):117-23.

Diffuse parenchymal lung disease in a case of chronic arsenic exposure.

Bhattacharya S, Dey A, Saha S, Kar S

Lung India : official organ of Indian Chest Society 2016; (33(5)):546-9 doi:10.4103/0970-2113.188980.

Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease: Bringing Together Clinical, Radiologic, and Histologic Clues.

Larsen BT, Smith ML, Elicker BM, et al.

Archives of pathology & laboratory medicine 2017; (141(7)):901-915 doi:10.5858/arpa.2016-0299-SA.

Interstitial lung disease in primary Sjögren's syndrome.

Roca F, Dominique S, Schmidt J, et al.

Autoimmunity reviews 2017; (16(1)):48-54 doi:10.1016/j.autrev.2016.09.017.

Interstitial Lung Disease in India. Results of a Prospective Registry.

Singh S, Collins BF, Sharma BB, et al.

American journal of respiratory and critical care medicine 2017; (195(6)):801-813 doi:10.1164/rccm.201607-1484OC.

Diffuse parenchymal lung disease.

Tomassetti S, Ravaglia C, Poletti V

European respiratory review : an official journal of the European Respiratory Society 2017; (26(144)) doi:10.1183/16000617.0004-2017.

Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis.

Spagnolo P, Wuyts W

Current opinion in pulmonary medicine 2017; (23(5)):411-417 doi:10.1097/MCP.0000000000000405.

Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis.

Jacob J, Bartholmai BJ, Rajagopalan S, et al.

The European respiratory journal 2017; (50(1)) doi:10.1183/13993003.00379-2017.

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.

Le Gouellec N, Duhamel A, Perez T, et al.

PloS one 2017; (12(8)):e0181692 doi:10.1371/journal.pone.0181692.

Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings.

Iwasawa T, Takemura T, Ogura T

Japanese journal of radiology 2018; (36(3)):165-180 doi:10.1007/s11604-017-0713-0.

Impact of Pulmonary Rehabilitation on Exercise Tolerance and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Gomes-Neto M, Silva CM, Ezequiel D, et al.

Journal of cardiopulmonary rehabilitation and prevention 2018; (38(5)):273-278 doi:10.1097/HCR.0000000000000273.

Comparison of CPI and GAP models in patients with idiopathic pulmonary fibrosis: a nationwide cohort study.

Lee SH, Park JS, Kim SY, et al.

Scientific reports 2018; (8(1)):4784 doi:10.1038/s41598-018-23073-3.

Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases: A Retrospective Observational Study of 938 Cases.

De Sadeleer LJ, Meert C, Yserbyt J, et al.

Chest 2018; (153(6)):1416-1423 doi:10.1016/j.chest.2018.03.026.

Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.

Caron M, Hoa S, Hudson M, et al.

European respiratory review : an official journal of the European Respiratory Society 2018; (27(148)) doi:10.1183/16000617.0102-2017.

Transbronchial Lung Cryobiopsy in Interstitial Lung Diseases: Best Practice.

Colella S, Haentschel M, Shah P, et al.

Respiration; international review of thoracic diseases 2018; (95(6)):383-391 doi:10.1159/000488910.

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.

Visca D, Mori L, Tsipouri V, et al.

The Lancet. Respiratory medicine 2018; (6(10)):759-770 doi:10.1016/S2213-2600(18)30289-3.

Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study.

Walsh SLF, Calandriello L, Silva M, Sverzellati N

The Lancet. Respiratory medicine 2018; (6(11)):837-845 doi:10.1016/S2213-2600(18)30286-8.

Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives.

Graney BA, Lee JS

Patient related outcome measures 2018; (9()):321-328 doi:10.2147/PROM.S144425.

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.

Jo HE, Glaspole I, Goh N, et al.

Respirology (Carlton, Vic.) 2019; (24(4)):361-368 doi:10.1111/resp.13427.

Exertional Desaturation and Prescription of Ambulatory Oxygen Therapy in Interstitial Lung Disease.

Khor YH, Goh NS, Glaspole I, et al.

Respiratory care 2019; (64(3)):299-306 doi:10.4187/respcare.06334.

The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.

Harari S, Caminati A, Confalonieri M, et al.

The clinical respiratory journal 2019; (13(3)):166-173 doi:10.1111/crj.12999.

Interstitial Lung Diseases in Developing Countries.

Rivera-Ortega P, Molina-Molina M

Annals of global health 2019; (85(1)) doi:10.5334/aogh.2414.

Tissue Continues to Be the Issue: Role of Histopathology in the Context of Recent Updates in the Radiologic Classification of Interstitial Lung Diseases.

Raparia K, Raj R

Archives of pathology & laboratory medicine 2019; (143(1)):30-33 doi:10.5858/arpa.2018-0134-RA.

The natural history of progressive fibrosing interstitial lung diseases.

Kolb M, Vašáková M

Respiratory research 2019; (20(1)):57 doi:10.1186/s12931-019-1022-1.

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study.

Richeldi L, Launders N, Martinez F, et al.

ERJ open research 2019; (5(2)) doi:10.1183/23120541.00209-2018.

Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib.

Wind S, Schmid U, Freiwald M, et al.

Clinical pharmacokinetics 2019; (58(9)):1131-1147 doi:10.1007/s40262-019-00766-0.

Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease.

Wells A, Devaraj A, Renzoni EA, Denton CP

Seminars in respiratory and critical care medicine 2019; (40(2)):184-193 doi:10.1055/s-0039-1684020.

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.

Hoffmann-Vold AM, Fretheim H, Halse AK, et al.

American journal of respiratory and critical care medicine 2019; (200(10)):1258-1266 doi:10.1164/rccm.201903-0486OC.

Lung Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: A Series Contribution to a Debated Procedure.

Harari S, Cereda F, Pane F, et al.

Medicina (Kaunas, Lithuania) 2019; (55(9)) doi:10.3390/medicina55090606.

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

Flaherty KR, Wells AU, Cottin V, et al.

The New England journal of medicine 2019; (381(18)):1718-1727 doi:10.1056/NEJMoa1908681.

Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis.

Wright JL, Churg A, Hague CJ, et al.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020; (33(4)):616-625 doi:10.1038/s41379-019-0389-3.

Treatment of the Connective Tissue Disease-Related Interstitial Lung Diseases: A Narrative Review.

Gao Y, Moua T

Mayo Clinic proceedings 2020; (95(3)):554-573 doi:10.1016/j.mayocp.2019.07.007.

Management issues in rheumatoid arthritis-associated interstitial lung disease.

England BR, Hershberger D

Current opinion in rheumatology 2020; (32(3)):255-263 doi:10.1097/BOR.0000000000000703.

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.

Wells AU, Flaherty KR, Brown KK, et al.

The Lancet. Respiratory medicine 2020; (8(5)):453-460 doi:10.1016/S2213-2600(20)30036-9.

Understanding cough in interstitial lung disease: a cross-sectional study on the adequacy of treatment.

Lan NSH, Moore I, Lake F

Internal medicine journal 2021; (51(6)):923-929 doi:10.1111/imj.14837.

Transbronchial Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Disease.

Mehrad M, Colby TV, Rossi G, Cavazza A

Archives of pathology & laboratory medicine 2020; (144(12)):1501-1508 doi:10.5858/arpa.2020-0007-RA.

Mechanical ventilation for acute respiratory failure due to idiopathic pulmonary fibrosis versus connective tissue disease-associated interstitial lung disease: Effectiveness and risk factors for death.

Luo Z, Yang L, Liu S, et al.

The clinical respiratory journal 2020; (14(10)):918-932 doi:10.1111/crj.13223.

Current therapies for patients with acute exacerbation of idiopathic pulmonary fibrosis.

Zhu LL, Dai HP, Wang C

Chinese medical journal 2020; (133(12)):1470-1472 doi:10.1097/CM9.0000000000000864.

Coronavirus disease 2019 pneumonia may present as an acute exacerbation of idiopathic pulmonary fibrosis.

Lee YH, Kim CH, Lee J

Journal of thoracic disease 2020; (12(7)):3902-3904 doi:10.21037/jtd-20-1658.

Managing Dyspnea in Individuals With Idiopathic Pulmonary Fibrosis.

Fenwick KE, Swan BA

Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association 2020; (22(6)):447-455 doi:10.1097/NJH.0000000000000687.

Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.

Makino S

Modern rheumatology 2021; (31(1)):13-19 doi:10.1080/14397595.2020.1826665.

Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.

Miyashita K, Kono M, Saito G, et al.

The clinical respiratory journal 2021; (15(3)):336-344 doi:10.1111/crj.13304.

The prevalence of obstructive sleep apnea in interstitial lung disease: a systematic review and meta-analysis.

Cheng Y, Wang Y, Dai L

Sleep & breathing = Schlaf & Atmung 2021; (25(3)):1219-1228 doi:10.1007/s11325-020-02282-z.

Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review.

Hoffmann-Vold AM, Maher TM, Philpot EE, et al.

ERJ open research 2021; (7(1)) doi:10.1183/23120541.00235-2020.

Three cases of sequential treatment with nintedanib following pulsed-dose corticosteroids for acute exacerbation of interstitial lung diseases.

Nakashima K, Yanagihara T, Ishida S, et al.

Respiratory medicine case reports 2021; (33()):101385 doi:10.1016/j.rmcr.2021.101385.

Rheumatoid arthritis related interstitial lung disease.

Manfredi A, Cassone G, Luppi F, et al.

Expert review of clinical immunology 2021; (17(5)):485-497 doi:10.1080/1744666X.2021.1905524.

Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: A single-center retrospective study.

Komatsu M, Yamamoto H, Kitaguchi Y, et al.

Medicine 2021; (100(13)):e25322 doi:10.1097/MD.0000000000025322.

Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP).

Hino T, Lee KS, Yoo H, et al.

European journal of radiology open 2021; (8()):100336 doi:10.1016/j.ejro.2021.100336.

Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.

Goos T, De Sadeleer LJ, Yserbyt J, et al.

Journal of clinical medicine 2021; (10(6)) doi:10.3390/jcm10061330.

Diagnosis and Management of Fibrotic Interstitial Lung Diseases.

Collins BF, Luppi F

Clinics in chest medicine 2021; (42(2)):321-335 doi:10.1016/j.ccm.2021.03.008.

The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease.

Swigris J, Cutts K, Male N, et al.

ERJ open research 2021; (7(2)) doi:10.1183/23120541.00145-2020.

Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis.

Sugino K, Ono H, Watanabe N, et al.

BMC pulmonary medicine 2021; (21(1)):218 doi:10.1186/s12890-021-01595-3.

An update on interstitial lung disease.

Mudawi D, Heyes K, Hastings R, et al.

British journal of hospital medicine (London, England : 2005) 2021; (82(7)):1-14 doi:10.12968/hmed.2020.0556.

Lung transplantation for interstitial lung disease.

Kapnadak SG, Raghu G

European respiratory review : an official journal of the European Respiratory Society 2021; (30(161)) doi:10.1183/16000617.0017-2021.

Clinical Impact of Surgical Lung Biopsy for Interstitial Lung Disease in a Reference Center.

Le Guen P, Iquille J, Debray MP, et al.

The Annals of thoracic surgery 2022; (114(3)):1022-1028 doi:10.1016/j.athoracsur.2021.07.038.

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Leard LE, Holm AM, Valapour M, et al.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2021; (40(11)):1349-1379 doi:10.1016/j.healun.2021.07.005.

Computed Tomography Findings Suggestive of Connective Tissue Disease in the Setting of Usual Interstitial Pneumonia.

Chung JH, Montner SM, Thirkateh P, et al.

Journal of computer assisted tomography 2021; (45(5)):776-781 doi:10.1097/RCT.0000000000001230.

Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.

Qiu M, Jiang J, Nian X, et al.

Respiratory research 2021; (22(1)):264 doi:10.1186/s12931-021-01856-z.

Airway complications in lung transplant recipients with telomere-related interstitial lung disease.

Choi B, Messika J, Courtwright A, et al.

Clinical transplantation 2022; (36(3)):e14552 doi:10.1111/ctr.14552.

Real-life prevalence of progressive fibrosing interstitial lung diseases.

Gagliardi M, Berg DV, Heylen CE, et al.

Scientific reports 2021; (11(1)):23988 doi:10.1038/s41598-021-03481-8.

Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease.

Wilfong EM, Aggarwal R

Therapeutic advances in musculoskeletal disease 2021; (13()):1759720X211060907 doi:10.1177/1759720X211060907.

Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis.

Bowman WS, Newton CA, Linderholm AL, et al.

The Lancet. Respiratory medicine 2022; (10(6)):593-602 doi:10.1016/S2213-2600(21)00503-8.

FVC-NET: An Automated Diagnosis of Pulmonary Fibrosis Progression Prediction Using Honeycombing and Deep Learning.

Yadav A, Saxena R, Kumar A, et al.

Computational intelligence and neuroscience 2022; (2022()):2832400 doi:10.1155/2022/2832400.

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis.

Mei Q, Liu Z, Zuo H, et al.

Frontiers in pharmacology 2021; (12()):797292 doi:10.3389/fphar.2021.797292.

COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review.

Goto Y, Sakamoto K, Fukihara J, et al.

Frontiers in medicine 2022; (9()):815924 doi:10.3389/fmed.2022.815924.

Interstitial lung disease in Primary Sjögren's syndrome.

Lin W, Xin Z, Zhang J, et al.

BMC pulmonary medicine 2022; (22(1)):73 doi:10.1186/s12890-022-01868-5.

Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis.

Chandel A, Pastre J, Valery S, et al.

Thorax 2023; (78(4)):368-375 doi:10.1136/thoraxjnl-2021-218440.

Current perspective of progressive-fibrosing interstitial lung disease.

Kishaba T

Respiratory investigation 2022; (60(4)):503-509 doi:10.1016/j.resinv.2022.03.004.

Clinical evidence for improving exercise tolerance and quality of life with pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Lei S, Li X, Xie Y, Li J

Clinical rehabilitation 2022; (36(8)):999-1015 doi:10.1177/02692155221095481.

IPF-Acute Exacerbations: Advances and Future Perspectives.

Papiris SA, Kolilekas L, Kagouridis K, et al.

Frontiers in pharmacology 2022; (13()):836553 doi:10.3389/fphar.2022.836553.

Mosaic attenuation in non-fibrotic areas as a predictor of non-usual interstitial pneumonia pathologic diagnosis.

Gayá García-Manso I, Arenas-Jiménez J, García-Sevila R, et al.

Scientific reports 2022; (12(1)):7289 doi:10.1038/s41598-022-10750-7.

Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures.

Wijsenbeek M, Molina-Molina M, Chassany O, et al.

ERJ open research 2022; (8(2)) doi:10.1183/23120541.00681-2021.

Indications for Lung Transplantation and Patient Selection.

Son J, Shin C

Journal of chest surgery 2022; (55(4)):255-264 doi:10.5090/jcs.22.057.

Towards Treatable Traits for Pulmonary Fibrosis.

Hoffman TW, Grutters JC

Journal of personalized medicine 2022; (12(8)) doi:10.3390/jpm12081275.

Reply to Noboa-Sevilla et al.

Vu Pugashetti J, Newton CA, Molyneaux PL, Oldham JM

American journal of respiratory and critical care medicine 2023; (207(3)):369-370 doi:10.1164/rccm.202209-1807LE.

Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis.

Rodrigues I, Estêvão Gomes R, Coutinho LM, et al.

European respiratory review : an official journal of the European Respiratory Society 2022; (31(166)) doi:10.1183/16000617.0280-2021.

Different chest HRCT scan protocols change the extent of ground glass opacities.

Emilsson ÖI, Dessle A, Johansson H, et al.

BMC pulmonary medicine 2022; (22(1)):430 doi:10.1186/s12890-022-02212-7.

Interstitial Lung Disease: A Focused Review for the Emergency Clinician.

Constantino K, Gottlieb M, Long B

The Journal of emergency medicine 2023; (64(2)):156-166 doi:10.1016/j.jemermed.2022.10.015.

Nintedanib in chILD: a small step, yes… but at least a step forward in a marathon!

Gozal D, Kolb M

The European respiratory journal 2023; (61(2)) doi:10.1183/13993003.01797-2022.

Machine Learning and BMI Improve the Prognostic Value of GAP Index in Treated IPF Patients.

Lacedonia D, De Pace CC, Rea G, et al.

Bioengineering (Basel, Switzerland) 2023; (10(2)) doi:10.3390/bioengineering10020251.

Lung transplantation for interstitial lung disease: evolution over three decades.

Leong SW, Bos S, Lordan JL, et al.

BMJ open respiratory research 2023; (10(1)) doi:10.1136/bmjresp-2022-001387.

Scanxiety among Adults with Cancer: A Scoping Review to Guide Research and Interventions.

Derry-Vick HM, Heathcote LC, Glesby N, et al.

Cancers 2023; (15(5)) doi:10.3390/cancers15051381.

Recent advances in the treatment of systemic sclerosis associated interstitial lung disease.

Kamenova A, Tzouvelekis A, Margaritopoulos GA

Frontiers in medicine 2023; (10()):1155771 doi:10.3389/fmed.2023.1155771.

Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience.

Boutel M, Boutou A, Pitsiou G, et al.

Diagnostics (Basel, Switzerland) 2023; (13(7)) doi:10.3390/diagnostics13071221.

Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease.

Wu Y, Li Y, Luo Y, et al.

Frontiers in immunology 2023; (14()):1146904 doi:10.3389/fimmu.2023.1146904.

"Scanxiety" and a sense of control: the perspective of lung cancer survivors and their caregivers on follow-up - a qualitative study.

Seibel K, Sauer B, Wagner B, Becker G

BMC psychology 2023; (11(1)):119 doi:10.1186/s40359-023-01151-0.

Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.

Matteson EL, Aringer M, Burmester GR, et al.

Clinical rheumatology 2023; (42(9)):2311-2319 doi:10.1007/s10067-023-06623-7.

External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis.

Chandel A, King CS, Ignacio RV, et al.

ERJ open research 2023; (9(3)) doi:10.1183/23120541.00124-2023.

A survival analysis of idiopathic pulmonary fibrosis in the context of antifibrotic therapy in Saudi Arabia.

Khan MA, Ghamdi BA, Alhamadi M, et al.

Annals of thoracic medicine 2023; (18(2)):79-85 doi:10.4103/atm.atm_264_22.

Fever in the initial stage of IIM patients: an early clinical warning sign for AE-ILD.

Liu T, Chen H, Shi Y, et al.

Advances in rheumatology (London, England) 2023; (63(1)):31 doi:10.1186/s42358-023-00313-3.

Updates in the New Guidelines for Idiopathic Pulmonary Fibrosis: Role of Cryobiopsy.

Cascante Rodrigo JA, Cebollero Rivas P

Open respiratory archives 2023; (5(1)):100226 doi:10.1016/j.opresp.2022.100226.

Occupational interstitial lung diseases.

Spagnolo P, Ryerson CJ, Guler S, et al.

Journal of internal medicine 2023; (294(6)):798-815 doi:10.1111/joim.13707.

Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis.

Maher TM, Stowasser S, Voss F, et al.

Respirology (Carlton, Vic.) 2023; (28(12)):1147-1153 doi:10.1111/resp.14579.

Role of Multidisciplinary Team Meetings in the Diagnosis and Management of Diffuse Parenchymal Lung Diseases in a Tertiary Care Hospital.

Khan MA, Sherbini N, Alyami S, et al.

Avicenna journal of medicine 2023; (13(4)):230-236 doi:10.1055/s-0043-1776063.

ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.

Hirata M, Hara Y, Fujii H, et al.

BMC pulmonary medicine 2024; (24(1)):16 doi:10.1186/s12890-023-02833-6.

Scanxiety and quality of life around follow-up imaging in patients with unruptured intracranial aneurysms: a prospective cohort study.

Kamphuis MJ, van der Kamp LT, van Eijk RPA, et al.

European radiology 2024; (34(9)):6018-6025 doi:10.1007/s00330-024-10602-0.

Connective tissue disease-associated interstitial lung disease.

Storrer KM, Müller CS, Pessoa MCA, Pereira CAC

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2024; (50(1)):e20230132 doi:10.36416/1806-3756/e20230132.

Evaluating Readability, Understandability, and Actionability of Online Printable Patient Education Materials for Cholesterol Management: A Systematic Review.

Bhatt C, Lin E, Ferreira-Legere LE, et al.

Journal of the American Heart Association 2024; (13(8)):e030140 doi:10.1161/JAHA.123.030140.

Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trial.

Kalverda KA, Ninaber MK, Wijmans L, et al.

The Lancet. Respiratory medicine 2024; (12(7)):513-522 doi:10.1016/S2213-2600(24)00074-2.

Interstitial Lung Disease: A Review.

Maher TM

JAMA 2024; (331(19)):1655-1665 doi:10.1001/jama.2024.3669.

Predictive factors of mortality in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a novel prognostic scoring system.

Polat G, Özdemir Ö, Ermin S, et al.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2024; (41(2)):e2024021 doi:10.36141/svdld.v41i2.13779.

Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis.

Weng C, Zhou Y, Zhang L, et al.

Seminars in arthritis and rheumatism 2024; (68()):152500 doi:10.1016/j.semarthrit.2024.152500.

A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial.

Solomon JJ, Hallowell RW, Ganslandt C, et al.

Respirology (Carlton, Vic.) 2025; (30(3)):253-261 doi:10.1111/resp.14859.

Stress Management Program for Scanxiety in People With Advanced Lung Cancer: Intervention Adaptation and Stakeholder Feedback.

Derry-Vick H, Khoudary A, Billini O, et al.

Psycho-oncology 2025; (34(1)):e70048 doi:10.1002/pon.70048.

The role of vascularity and the fibrovascular interface in interstitial lung diseases.

Dietrich J, Kang A, Tielemans B, et al.

European respiratory review : an official journal of the European Respiratory Society 2025; (34(175)) doi:10.1183/16000617.0080-2024.

Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life Study.

Aycicek O, Keskin S, Haciosmanoglu M, et al.

Medicina (Kaunas, Lithuania) 2025; (61(2)) doi:10.3390/medicina61020283.

Prognostic Utility of the GAP Score in Interstitial Lung Disease Patients Evaluated for Lung Transplantation: A Single-Center Study.

Mora-Cuesta VM, Zuazaga-Fuentes J, Iturbe-Fernández D, et al.

Clinical transplantation 2025; (39(3)):e70136 doi:10.1111/ctr.70136.

Advances in management of pulmonary fibrosis.

Lachowicz JA, Steinfort DP, Smallwood NE, Prasad JD

Internal medicine journal 2025; (55(7)):1070-1080 doi:10.1111/imj.70051.

[Indications for Lung Transplantation - Updates Since the Last ISHLT Recommendations].

Kovacs Z, Benazzo A, Jaksch P

Zentralblatt fur Chirurgie 2025; (150(3)):256-260 doi:10.1055/a-2563-3691.

Patient characteristics and pharmacologic treatment patterns in antifibrotic-treated patients with fibrosing interstitial lung diseases: real-world results from a claims database.

Kondoh Y, Ito T, Kimura H, et al.

BMC pulmonary medicine 2025; (25(1)):253 doi:10.1186/s12890-025-03713-x.

Current State of Fibrotic Interstitial Lung Disease Imaging.

Chelala L, Brixey AG, Hobbs SB, et al.

Radiology 2025; (316(1)):e242531 doi:10.1148/radiol.242531.

Ambulatory Oxygen for Pulmonary Fibrosis (OxyPuF): a randomised controlled trial and acceptability study.

Adams RL, Maher A, Gale N, et al.

Health technology assessment (Winchester, England) 2025; 1-33 doi:10.3310/TWKS4194.

Validation of the gender, age, physiology model and other prognostic factors in interstitial lung disease patients with systemic autoimmune rheumatic disease.

Hwang YJ, Lee JK, Lee JH, et al.

Scientific reports 2025; (15(1)):24691 doi:10.1038/s41598-025-08484-3.

Progressive pulmonary fibrosis: current perspectives in diagnostic imaging.

Agarwal P, Schlett CL, Bamberg F, Frye BC

BJR open 2025; (7(1)):tzaf018 doi:10.1093/bjro/tzaf018.

Prevalence, severity, and modifiable predictors of scanxiety in patients undergoing routine oncologic imaging: a prospective longitudinal study.

Shah MS, Memon JA, Malik U, et al.

Clinical imaging 2025; (128()):110634 doi:10.1016/j.clinimag.2025.110634.

Treatment Response and Safety Profile of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease: A Retrospective Observational Study.

Gkouvi A, Boutel M, Zioga N, et al.

Mediterranean journal of rheumatology 2025; (36(3)):370-379 doi:10.31138/mjr.080825.lfh.

"You Always Worry": Scan-Related Anxiety Among Patients With Metastatic Lung Cancer.

Derry-Vick H, Prigerson HG, Hahne J, et al.

Journal of the American College of Radiology : JACR 2025; (22(12)):1572-1577 doi:10.1016/j.jacr.2025.08.021.

Immunopathogenic Mechanisms in Connective Tissue Disease-Associated Interstitial Lung Disease: Incessant Loop of Immunity to Fibrosis.

Lee JH, Jang JH, Lee S, Her M

International journal of molecular sciences 2025; (26(24)) doi:10.3390/ijms262412126.

[Air travel and oxygen therapy for passengers with respiratory diseases].

Sorichter S, Sorichter AM, Scholz T

Laryngo- rhino- otologie 2026; (105(1)):47-62 doi:10.1055/a-2727-0843.

Research Progress of Interstitial Lung Disease Based on Single-Cell Sequencing Technology.

Li S, Zhou T, Zhang J, et al.

Canadian respiratory journal 2026; (2026()):8863968 doi:10.1155/carj/8863968.

Advances in the Diagnosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Integrating Conventional Tools and Emerging Biomarkers.

Bai J, Yu F, He X

International journal of molecular sciences 2026; (27(3)) doi:10.3390/ijms27031165.